{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:59:57Z","timestamp":1786737597293,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R16GM145586"],"award-info":[{"award-number":["1R16GM145586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a chronic degenerative brain disorder with no clear pathogenesis or effective cure, accounting for 60\u201380% of cases of dementia. In recent years, the importance of neuroinflammation in the pathogenesis of AD and other neurodegenerative disorders has come into focus. Previously, we made the serendipitous discovery that the widely used drug excipient N,N-dimethylacetamide (DMA) attenuates endotoxin-induced inflammatory responses in vivo. In the current work, we investigate the effect of DMA on neuroinflammation and its mechanism of action in in-vitro and ex-vivo models of AD. We show that DMA significantly suppresses the production of inflammatory mediators, such as reactive oxygen species (ROS), nitric oxide (NO) and various cytokines and chemokines, as well as amyloid-\u03b2 (A\u03b2), in cultured microglia and organotypic hippocampal slices induced by lipopolysaccharide (LPS). We also demonstrate that DMA inhibits A\u03b2-induced inflammation. Finally, we show that the mechanism of DMA\u2019s effect on neuroinflammation is inhibition of the nuclear factor kappa-B (NF-\u03baB) signaling pathway and we show how DMA dismantles the positive feedback loop between NF-\u03baB and A\u03b2 synthesis. Taken together, our findings suggest that DMA, a generally regarded as safe compound that crosses the blood brain barrier, should be further investigated as a potential therapy for Alzheimer\u2019s disease and neuroinflammatory disorders.<\/jats:p>","DOI":"10.1038\/s41598-023-34355-w","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T07:02:23Z","timestamp":1682924543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["N,N-dimethylacetamide targets neuroinflammation in Alzheimer\u2019s disease in in-vitro and ex-vivo models"],"prefix":"10.1038","volume":"13","author":[{"given":"Zeng-Hui","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Acharekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Trejos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Duo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Schanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles R.","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"issue":"Suppl","key":"34355_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato, D. J., Quan, N. & Godbout, J. P. Neuroinflammation: The devil is in the details. J. Neurochem. 139(Suppl), 136\u2013153. https:\/\/doi.org\/10.1111\/jnc.13607 (2016).","journal-title":"J. Neurochem."},{"key":"34355_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fncel.2018.00306","volume":"12","author":"L Zhang","year":"2018","unstructured":"Zhang, L., Zhang, J. & You, Z. Switching of the microglial activation phenotype is a possible treatment for depression disorder. Front. Cell Neurosci. 12, 306. https:\/\/doi.org\/10.3389\/fncel.2018.00306 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"34355_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052342","author":"G Piccioni","year":"2021","unstructured":"Piccioni, G., Mango, D., Saidi, A., Corbo, M. & Nistic\u00f2, R. Targeting microglia-synapse interactions in Alzheimer\u2019s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22052342 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"34355_CR4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey, M. G. & Goldberg, M. S. Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37, 510\u2013518. https:\/\/doi.org\/10.1016\/j.nbd.2009.11.004 (2010).","journal-title":"Neurobiol. Dis."},{"key":"34355_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/0046-8177(95)90001-2","volume":"26","author":"RE Mrak","year":"1995","unstructured":"Mrak, R. E., Sheng, J. G. & Griffin, W. S. Glial cytokines in Alzheimer\u2019s disease: Review and pathogenic implications. Hum. Pathol. 26, 816\u2013823. https:\/\/doi.org\/10.1016\/0046-8177(95)90001-2 (1995).","journal-title":"Hum. Pathol."},{"key":"34355_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10203-8","author":"K Maurer","year":"1997","unstructured":"Maurer, K., Volk, S. & Gerbaldo, H. Auguste D and Alzheimer\u2019s disease. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(96)10203-8 (1997).","journal-title":"Lancet"},{"key":"34355_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(97)00035-6","author":"MM Weber","year":"1997","unstructured":"Weber, M. M. Aloys Alzheimer, a coworker of Emil Kraepelin. J. Psychiatr. Res. https:\/\/doi.org\/10.1016\/S0022-3956(97)00035-6 (1997).","journal-title":"J. Psychiatr. Res."},{"key":"34355_CR8","doi-asserted-by":"publisher","first-page":"687157","DOI":"10.3389\/fnins.2021.687157","volume":"15","author":"Z Wei","year":"2021","unstructured":"Wei, Z., Koya, J. & Reznik, S. E. Insulin resistance exacerbates Alzheimer disease via multiple mechanisms. Front. Neurosci. 15, 687157. https:\/\/doi.org\/10.3389\/fnins.2021.687157 (2021).","journal-title":"Front. Neurosci."},{"key":"34355_CR9","unstructured":"WHO. Dementia Fact Sheet (WHO, 2021)."},{"key":"34355_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jnc.14687","volume":"150","author":"NK Jha","year":"2019","unstructured":"Jha, N. K. et al. Nuclear factor-kappa \u03b2 as a therapeutic target for Alzheimer\u2019s disease. J. Neurochem. 150, 113\u2013137. https:\/\/doi.org\/10.1111\/jnc.14687 (2019).","journal-title":"J. Neurochem."},{"key":"34355_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","volume":"29","author":"AB Reiss","year":"2018","unstructured":"Reiss, A. B., Arain, H. A., Stecker, M. M., Siegart, N. M. & Kasselman, L. J. Amyloid toxicity in Alzheimer\u2019s disease. Rev. Neurosci. 29, 613\u2013627. https:\/\/doi.org\/10.1515\/revneuro-2017-0063 (2018).","journal-title":"Rev. Neurosci."},{"key":"34355_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5469","author":"FB Ahmad","year":"2021","unstructured":"Ahmad, F. B. & Anderson, R. N. The leading causes of death in the US for 2020. JAMA https:\/\/doi.org\/10.1001\/jama.2021.5469 (2021).","journal-title":"JAMA"},{"key":"34355_CR13","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1037\/a0029857","volume":"27","author":"RS Wilson","year":"2012","unstructured":"Wilson, R. S. et al. The natural history of cognitive decline in Alzheimer\u2019s disease. Psychol. Aging 27, 1008\u20131017. https:\/\/doi.org\/10.1037\/a0029857 (2012).","journal-title":"Psychol. Aging"},{"key":"34355_CR14","unstructured":"Heron, M. Deaths: leading causes for 2010. Natl Vital Stat Reports 62 (2013)."},{"key":"34355_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz, C. & Mayeux, R. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88, 640\u2013651. https:\/\/doi.org\/10.1016\/j.bcp.2013.12.024 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"34355_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","volume":"3","author":"W-Y Wang","year":"2015","unstructured":"Wang, W.-Y., Tan, M.-S., Yu, J.-T. & Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann. Transl. Med. 3, 136. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.49 (2015).","journal-title":"Ann. Transl. Med."},{"key":"34355_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0000000000000320","author":"AB Reiss","year":"2021","unstructured":"Reiss, A. B. et al. Alzheimer disease clinical trials targeting amyloid: Lessons learned from success in mice and failure in humans. Neurologist https:\/\/doi.org\/10.1097\/NRL.0000000000000320 (2021).","journal-title":"Neurologist"},{"key":"34355_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0609-7","author":"LK Huang","year":"2020","unstructured":"Huang, L. K., Chao, S. P. & Hu, C. J. Clinical trials of new drugs for Alzheimer disease. J. Biomed. Sci. https:\/\/doi.org\/10.1186\/s12929-019-0609-7 (2020).","journal-title":"J. Biomed. Sci."},{"key":"34355_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25410","author":"F Panza","year":"2019","unstructured":"Panza, F., Lozupone, M., Seripa, D. & Imbimbo, B. P. Amyloid-\u03b2 immunotherapy for Alzheimer disease: Is it now a long shot?. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.25410 (2019).","journal-title":"Ann. Neurol."},{"key":"34355_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon, E. E. & Sigurdsson, E. M. Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 14, 99\u2013415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"34355_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00401-018-1918-8","volume":"136","author":"GP Morris","year":"2018","unstructured":"Morris, G. P., Clark, I. A. & Vissel, B. Questions concerning the role of amyloid-\u03b2 in the definition, aetiology and diagnosis of Alzheimer\u2019s disease. Acta Neuropathol. 136, 663\u2013689. https:\/\/doi.org\/10.1007\/s00401-018-1918-8 (2018).","journal-title":"Acta Neuropathol."},{"key":"34355_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40478-014-0135-5","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris, G. P., Clark, I. A. & Vissel, B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease. Acta Neuropathol. Commun 2, 135. https:\/\/doi.org\/10.1186\/s40478-014-0135-5 (2014).","journal-title":"Acta Neuropathol. Commun"},{"key":"34355_CR23","doi-asserted-by":"publisher","first-page":"e0201878","DOI":"10.1371\/journal.pone.0201878","volume":"13","author":"F Brabazon","year":"2018","unstructured":"Brabazon, F., Bermudez, S., Shaughness, M., Khayrullina, G. & Byrnes, K. R. The effects of insulin on the inflammatory activity of BV2 microglia. PLoS ONE 13, e0201878. https:\/\/doi.org\/10.1371\/journal.pone.0201878 (2018).","journal-title":"PLoS ONE"},{"key":"34355_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2016.09.073","volume":"479","author":"M Go","year":"2016","unstructured":"Go, M., Kou, J., Lim, J.-E., Yang, J. & Fukuchi, K.-I. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer\u2019s mouse model: Implication of TLR4 signaling in disease progression. Biochem. Biophys. Res. Commun. 479, 331\u2013337. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.073 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"34355_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1006\/bbrc.1995.1757","volume":"210","author":"WW Wang","year":"1995","unstructured":"Wang, W. W. et al. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210, 1009\u20131016. https:\/\/doi.org\/10.1006\/bbrc.1995.1757 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"34355_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-5-37","volume":"5","author":"JW Lee","year":"2008","unstructured":"Lee, J. W. et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflammation 5, 37. https:\/\/doi.org\/10.1186\/1742-2094-5-37 (2008).","journal-title":"J. Neuroinflammation"},{"key":"34355_CR27","doi-asserted-by":"publisher","first-page":"e12179","DOI":"10.1002\/trc2.12179","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings, J., Lee, G., Zhong, K., Fonseca, J. & Taghva, K. Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimer\u2019s Dement. 7, e12179. https:\/\/doi.org\/10.1002\/trc2.12179 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"34355_CR28","doi-asserted-by":"publisher","first-page":"104814","DOI":"10.1016\/j.nbd.2020.104814","volume":"140","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation. Neurobiol. Dis. 140, 104814. https:\/\/doi.org\/10.1016\/j.nbd.2020.104814 (2020).","journal-title":"Neurobiol. Dis."},{"key":"34355_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2119\/molmed.2016.00017","volume":"22","author":"R Pekson","year":"2016","unstructured":"Pekson, R. et al. N,N-Dimethylacetamide significantly attenuates LPS- and TNF\u03b1-induced proinflammatory responses via inhibition of the nuclear factor kappa B pathway. Mol. Med. 22, 747\u2013758. https:\/\/doi.org\/10.2119\/molmed.2016.00017 (2016).","journal-title":"Mol. Med."},{"key":"34355_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnmol.2016.00118","volume":"9","author":"WM Snow","year":"2016","unstructured":"Snow, W. M. & Albensi, B. C. Neuronal gene targets of NF-\u03baB and their dysregulation in Alzheimer\u2019s disease. Front. Mol. Neurosci. 9, 118. https:\/\/doi.org\/10.3389\/fnmol.2016.00118 (2016).","journal-title":"Front. Mol. Neurosci."},{"key":"34355_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/ijms21010209","volume":"21","author":"T Zhang","year":"2019","unstructured":"Zhang, T., Chen, D. & Lee, T. H. Phosphorylation signaling in APP processing in Alzheimer\u2019s disease. Int. J. Mol. Sci. 21, 209. https:\/\/doi.org\/10.3390\/ijms21010209 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"34355_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1567205013666160930110551","volume":"14","author":"B Decourt","year":"2017","unstructured":"Decourt, B., Lahiri, D. K. & Sabbagh, M. N. Targeting tumor necrosis factor alpha for Alzheimer\u2019s disease. Curr. Alzheimer Res. 14, 412\u2013425. https:\/\/doi.org\/10.2174\/1567205013666160930110551 (2017).","journal-title":"Curr. Alzheimer Res."},{"issue":"2011","key":"34355_CR33","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.ajpath.2011.07.001","volume":"179","author":"SL Montgomery","year":"2011","unstructured":"Montgomery, S. L. et al. Ablation of TNF-RI\/RII expression in Alzheimer\u2019s disease mice leads to an unexpected enhancement of pathology: Implications for chronic pan-TNF-\u03b1 suppressive therapeutic strategies in the brain. Am. J. Pathol. 179(2011), 2053\u20132070. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.001 (2011).","journal-title":"Am. J. Pathol."},{"key":"34355_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/jir.s4397","volume":"1","author":"FE McAlpine","year":"2008","unstructured":"McAlpine, F. E. & Tansey, M. G. Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer\u2019s disease. J. Inflamm. Res. 1, 29\u201339. https:\/\/doi.org\/10.2147\/jir.s4397 (2008).","journal-title":"J. Inflamm. Res."},{"key":"34355_CR35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402034200","author":"YF Liaoi","year":"2004","unstructured":"Liaoi, Y. F., Wang, B. J., Cheng, H. T., Kuo, L. H. & Wolfe, M. S. Tumor necrosis factor-\u03b1, interleukin-1\u03b2, and interferon-\u03b3 stimulate \u03b3-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M402034200 (2004).","journal-title":"J. Biol. Chem."},{"key":"34355_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ajpath.2013.05.006","volume":"183","author":"S Sundaram","year":"2013","unstructured":"Sundaram, S. et al. N,N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth. Am. J. Pathol. 183, 422\u2013430. https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.006 (2013).","journal-title":"Am. J. Pathol."},{"key":"34355_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.26502\/fjhs.076","volume":"5","author":"J Koya","year":"2022","unstructured":"Koya, J. et al. FDA-approved excipient N,N-dimethylacetamide attenuates in vitro and in vivo inflammatory bowel disease. Fortune J. Health Sci. 5, 499\u2013509. https:\/\/doi.org\/10.26502\/fjhs.076 (2022).","journal-title":"Fortune J. Health Sci."},{"key":"34355_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep42108","author":"C Ghayor","year":"2017","unstructured":"Ghayor, C. et al. N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment. Sci. Rep. https:\/\/doi.org\/10.1038\/srep42108 (2017).","journal-title":"Sci. Rep."},{"key":"34355_CR39","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3389\/fphar.2019.01274","volume":"10","author":"I Bhattacharya","year":"2019","unstructured":"Bhattacharya, I., Ghayor, C., P\u00e9rez Dominguez, A. & Weber, F. E. N, N-dimethlyacetamide prevents the high-fat diet-induced increase in body weight. Front. Pharmacol. 10, 1274. https:\/\/doi.org\/10.3389\/fphar.2019.01274 (2019).","journal-title":"Front. Pharmacol."},{"key":"34355_CR40","doi-asserted-by":"publisher","first-page":"fcaa002","DOI":"10.1093\/braincomms\/fcaa002","volume":"2","author":"J Merisaari","year":"2020","unstructured":"Merisaari, J. et al. Monotherapy efficacy of blood\u2013brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma. Brain Commun. 2, fcaa002. https:\/\/doi.org\/10.1093\/braincomms\/fcaa002 (2020).","journal-title":"Brain Commun."},{"key":"34355_CR41","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1200\/JCO.2006.08.8807","volume":"25","author":"G Hempel","year":"2007","unstructured":"Hempel, G. et al. Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 25, 1772\u20131778. https:\/\/doi.org\/10.1200\/JCO.2006.08.8807 (2007).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"34355_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fimmu.2020.00162","volume":"11","author":"Y An","year":"2020","unstructured":"An, Y., Zhang, H., Huang, S. & Pei, G. PL201, a reported rhamnoside against Alzheimer\u2019s disease pathology, alleviates neuroinflammation and stimulates Nrf2 signaling. Front. Immunol. 11, 162. https:\/\/doi.org\/10.3389\/fimmu.2020.00162 (2020).","journal-title":"Front. Immunol."},{"key":"34355_CR43","doi-asserted-by":"publisher","first-page":"e12754","DOI":"10.1111\/acel.12754","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. nNOS-CAPON interaction mediates amyloid-\u03b2-induced neurotoxicity, especially in the early stages. Aging Cell 17, e12754\u2013e12754. https:\/\/doi.org\/10.1111\/acel.12754 (2018).","journal-title":"Aging Cell"},{"key":"34355_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fnmol.2017.00221","volume":"10","author":"V Lasarevic","year":"2017","unstructured":"Lasarevic, V. et al. Physiological concentrations of amyloid beta regulate recycling of synaptic vesicles via alpha7 acetylcholine receptor and CDK5\/calcineurin signaling. Front. Mol. Neurosci. 10, 221. https:\/\/doi.org\/10.3389\/fnmol.2017.00221 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"34355_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2466","author":"JO Lundberg","year":"2008","unstructured":"Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/nrd2466 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"34355_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-97894-0","volume":"11","author":"MC Cox","year":"2021","unstructured":"Cox, M. C. et al. Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models. Sci. Rep. 11, 1\u201314. https:\/\/doi.org\/10.1038\/s41598-021-97894-0 (2021).","journal-title":"Sci. Rep."},{"key":"34355_CR47","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ajpath.2014.10.026","volume":"185","author":"V Vyas","year":"2015","unstructured":"Vyas, V. et al. Inhibition of sphingosine kinase prevents lipopolysaccharide-induced preterm birth and suppresses proinflammatory responses in a murine model. Am. J. Pathol. 185, 862\u2013869. https:\/\/doi.org\/10.1016\/j.ajpath.2014.10.026 (2015).","journal-title":"Am. J. Pathol."},{"key":"34355_CR48","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3390\/ijms19123805","volume":"19","author":"Q Xue","year":"2018","unstructured":"Xue, Q., Yan, Y., Zhang, R. & Xiong, H. Regulation of iNOS on immune cells and its role in diseases. Int. J. Mol. Sci. 19, 3805. https:\/\/doi.org\/10.3390\/ijms19123805 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"34355_CR49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes, D. E. & Yaffe, K. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 10, 819\u2013828. https:\/\/doi.org\/10.1016\/S1474-4422(11)70072-2 (2011).","journal-title":"Lancet Neurol."},{"key":"34355_CR50","doi-asserted-by":"publisher","unstructured":"2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 17, 327\u2013406. https:\/\/doi.org\/10.1002\/alz.12328.","DOI":"10.1002\/alz.12328"},{"key":"34355_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.3063","author":"KA Matthews","year":"2019","unstructured":"Matthews, K. A. et al. Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged \u226565 years. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.3063 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"34355_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0297-z","author":"M Crous-Bou","year":"2017","unstructured":"Crous-Bou, M., Minguill\u00f3n, C., Gramunt, N. & Molinuevo, J. L. Alzheimer\u2019s disease prevention: From risk factors to early intervention. Alzheimer\u2019s Res. Ther. https:\/\/doi.org\/10.1186\/s13195-017-0297-z (2017).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"34355_CR53","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011832","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. Long-term effects of cholinesterase inhibitors on cognitive decline and mortality. Neurology https:\/\/doi.org\/10.1212\/WNL.0000000000011832 (2021).","journal-title":"Neurology"},{"key":"34355_CR54","first-page":"1403","volume":"83","author":"BT Winslow","year":"2011","unstructured":"Winslow, B. T., Onysko, M. K., Stob, C. M. & Hazlewood, K. A. Treatment of Alzheimer disease. Am. Fam. Physician 83, 1403\u20131412 (2011).","journal-title":"Am. Fam. Physician"},{"key":"34355_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.14283\/jpad.2017.39","volume":"4","author":"BS Haeberlein","year":"2017","unstructured":"Haeberlein, B. S. et al. Clinical development of aducanumab, an anti-A\u03b2 human monoclonal antibody being investigated for the treatment of early Alzheimer\u2019s disease. J. Prev. Alzheimer\u2019s Dis. 4, 255\u2013263. https:\/\/doi.org\/10.14283\/jpad.2017.39 (2017).","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"34355_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41582-019-0295-9","volume":"16","author":"R Howard","year":"2020","unstructured":"Howard, R. & Liu, K. Y. Questions EMERGE as Biogen claims aducanumab turnaround. Nat. Rev. Neurol. 16, 63\u201364. https:\/\/doi.org\/10.1038\/s41582-019-0295-9 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"34355_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1474-4422(19)30480-6","volume":"19","author":"L Schneider","year":"2020","unstructured":"Schneider, L. A resurrection of aducanumab for Alzheimer\u2019s disease. Lancet Neurol. 19, 111\u2013112. https:\/\/doi.org\/10.1016\/S1474-4422(19)30480-6 (2020).","journal-title":"Lancet Neurol."},{"key":"34355_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8416763","author":"G Pizzino","year":"2017","unstructured":"Pizzino, G. et al. Oxidative stress: Harms and benefits for human health. Oxid. Med. Cell Longev. https:\/\/doi.org\/10.1155\/2017\/8416763 (2017).","journal-title":"Oxid. Med. Cell Longev."},{"key":"34355_CR59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bj.2017.06.007","volume":"40","author":"S Hurrle","year":"2017","unstructured":"Hurrle, S. & Hsu, W. H. The etiology of oxidative stress in insulin resistance. Biomed. J. 40, 257\u2013262. https:\/\/doi.org\/10.1016\/j.bj.2017.06.007 (2017).","journal-title":"Biomed. J."},{"key":"34355_CR60","doi-asserted-by":"publisher","first-page":"01","DOI":"10.1124\/jpet.116.237503","volume":"360","author":"S Salim","year":"2017","unstructured":"Salim, S. Oxidative stress and the central nervous system. J. Pharmacol. Exp. Ther. 360, 01\u2013205. https:\/\/doi.org\/10.1124\/jpet.116.237503 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"34355_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","volume":"77","author":"SM de la Monte","year":"2017","unstructured":"de la Monte, S. M. Insulin resistance and neurodegeneration: Progress towards the development of new therapeutics for Alzheimer\u2019s disease. Drugs 77, 47\u201365. https:\/\/doi.org\/10.1007\/s40265-016-0674-0 (2017).","journal-title":"Drugs"},{"key":"34355_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"W Dr\u00f6ge","year":"2002","unstructured":"Dr\u00f6ge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47\u201395. https:\/\/doi.org\/10.1152\/physrev.00018.2001 (2002).","journal-title":"Physiol. Rev."},{"key":"34355_CR63","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.cellsig.2007.04.009","volume":"19","author":"M Genestra","year":"2007","unstructured":"Genestra, M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 19, 1807\u20131819. https:\/\/doi.org\/10.1016\/j.cellsig.2007.04.009 (2007).","journal-title":"Cell Signal."},{"key":"34355_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.12.004","volume":"91","author":"F Di Domenico","year":"2016","unstructured":"Di Domenico, F. et al. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients. Free Radic. Biol. Med. 91, 1\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.12.004 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"34355_CR65","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon, C. et al. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol. 14, 450\u2013464. https:\/\/doi.org\/10.1016\/j.redox.2017.10.014 (2018).","journal-title":"Redox Biol."},{"key":"34355_CR66","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","volume":"4","author":"W-J Huang","year":"2016","unstructured":"Huang, W.-J., Zhang, X. & Chen, W.-W. Role of oxidative stress in Alzheimer\u2019s disease. Biomed. Rep. 4, 519\u2013522. https:\/\/doi.org\/10.3892\/br.2016.630 (2016).","journal-title":"Biomed. Rep."},{"key":"34355_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher, P., Beckman, J. S. & Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 15\u2013424. https:\/\/doi.org\/10.1152\/physrev.00029.2006 (2007).","journal-title":"Physiol. Rev."},{"key":"34355_CR68","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrd2222","volume":"6","author":"C Szab\u00f3","year":"2007","unstructured":"Szab\u00f3, C., Ischiropoulos, H. & Radi, R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6, 662\u2013680. https:\/\/doi.org\/10.1038\/nrd2222 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"34355_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.08.018","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla, R., Thirumala, V. & Reddy, P. H. Is Alzheimer\u2019s disease a Type 3 diabetes? A critical appraisal. Biochim. Biophys. Acta Mol. Basis Dis. https:\/\/doi.org\/10.1016\/j.bbadis.2016.08.018 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"34355_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.06.029","author":"X Cheng","year":"2014","unstructured":"Cheng, X., Shen, Y. & Li, R. Targeting TNF: A therapeutic strategy for Alzheimer\u2019s disease. Drug Discov. Today. https:\/\/doi.org\/10.1016\/j.drudis.2014.06.029 (2014).","journal-title":"Drug Discov. Today."},{"key":"34355_CR71","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/ijms22031347","volume":"22","author":"A Amend","year":"2021","unstructured":"Amend, A. et al. Dual role of interleukin-10 in murine NZB\/W F1 lupus. Int. J. Mol. Sci. 22, 1347. https:\/\/doi.org\/10.3390\/ijms22031347 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"34355_CR72","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","volume":"127","author":"T Shabab","year":"2017","unstructured":"Shabab, T., Khanabdali, R., Moghadamtousi, S. Z., Kadir, H. A. & Mohan, G. Neuroinflammation pathways: A general review. Int. J. Neurosci. 127, 624\u2013633. https:\/\/doi.org\/10.1080\/00207454.2016.1212854 (2017).","journal-title":"Int. J. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34355-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34355-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34355-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T07:03:41Z","timestamp":1682924621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34355-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34355"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34355-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2363746\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"10 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SER and CRA Jr. have a patent pending (US 13\/536,946) for the use of N,N-dimethylacetamide in inflammatory disorders.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7077"}}